Philadelphia Trust CO Moderna, Inc. Transaction History

Philadelphia Trust CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$69.51 - $104.43 $22,590 - $33,939	-325 Reduced 12.97%	2,180 $217,000
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $11,807 - $19,418	-100 Reduced 3.84%	2,505 $296,000
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $27,525 - $41,498	-235 Reduced 8.27%	2,605 $372,000
Q1 2022 May 05, 2022	SELL	$126.46 - $235.05 $18,969 - $35,257	-150 Reduced 5.02%	2,840 $489,000
Q4 2021 Feb 09, 2022	SELL	$225.82 - $368.51 $84,682 - $138,191	-375 Reduced 11.14%	2,990 $759,000
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $11,095 - $24,223	-50 Reduced 1.46%	3,365 $1.3 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $40,921 - $74,018	315 Added 10.16%	3,415 $802,000
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $2,183 - $3,719	20 Added 0.65%	3,100 $406,000
Q4 2020 Feb 08, 2021	BUY	$65.74 - $169.86 $202,479 - $523,168	3,080 New	3,080 $322,000
Q3 2020 Nov 12, 2020	SELL	$54.34 - $94.85 $231,216 - $403,586	-4,255 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $126,245 - $340,400	4,255 New	4,255 $273,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Philadelphia Trust CO, based on Form 13F filings with the SEC.

Stay updated on Philadelphia Trust CO with notifications on news.